C4 Therapeutics, Inc. - 10-Q Filing
C4 Therapeutics reports Q3 2026 financial position and updates on collaborative milestone agreements with Roche, Merck KGaA, and Betta Pharmaceuticals.
Tickers: $CCCC
C4 Therapeutics reports Q3 2026 financial position and updates on collaborative milestone agreements with Roche, Merck KGaA, and Betta Pharmaceuticals.
Tickers: $CCCC